HOXD1
gene geneOn this page
Summary
HOXD1 (homeobox D1, HGNC:5132) is a protein-coding gene on chromosome 2q31.1, encoding Homeobox protein Hox-D1 (Q9GZZ0). Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
This gene is a member of the Antp homeobox family and encodes a protein with a homeobox DNA-binding domain. This nuclear protein functions as a sequence-specific transcription factor that is involved in differentiation and limb development. Mutations in this gene have been associated with severe developmental defects on the anterior-posterior (a-p) limb axis.
Source: NCBI Gene 3231 — RefSeq curated summary.
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 42 total — 1 pathogenic
- MANE Select transcript:
NM_024501
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:5132 |
| Approved symbol | HOXD1 |
| Name | homeobox D1 |
| Location | 2q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000128645 |
| Ensembl biotype | protein_coding |
| OMIM | 142987 |
| Entrez | 3231 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000331462, ENST00000876788
RefSeq mRNA: 1 — MANE Select: NM_024501
NM_024501
CCDS: CCDS2271
Canonical transcript exons
ENST00000331462 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000882927 | 176188668 | 176189453 |
| ENSE00002391549 | 176189808 | 176190907 |
Expression profiles
Bgee: expression breadth ubiquitous, 185 present calls, max score 86.45.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4170 / max 54.2742, expressed in 334 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 23874 | 1.4170 | 334 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 86.45 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.32 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 85.57 | gold quality |
| renal glomerulus | UBERON:0000074 | 85.22 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 83.67 | gold quality |
| secondary oocyte | CL:0000655 | 83.33 | gold quality |
| spinal cord | UBERON:0002240 | 82.88 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 82.02 | gold quality |
| caput epididymis | UBERON:0004358 | 81.62 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.53 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 81.11 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 80.94 | gold quality |
| seminal vesicle | UBERON:0000998 | 80.73 | gold quality |
| oocyte | CL:0000023 | 80.44 | gold quality |
| colonic mucosa | UBERON:0000317 | 79.82 | gold quality |
| kidney epithelium | UBERON:0004819 | 79.50 | gold quality |
| inferior olivary complex | UBERON:0002127 | 78.65 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 78.33 | gold quality |
| metanephros | UBERON:0000081 | 77.63 | gold quality |
| nephron tubule | UBERON:0001231 | 77.45 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 76.82 | gold quality |
| medulla oblongata | UBERON:0001896 | 76.08 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 74.91 | silver quality |
| cortex of kidney | UBERON:0001225 | 74.33 | gold quality |
| ileal mucosa | UBERON:0000331 | 74.17 | gold quality |
| right uterine tube | UBERON:0001302 | 73.13 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 72.98 | silver quality |
| visceral pleura | UBERON:0002401 | 72.86 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.83 | gold quality |
| substantia nigra | UBERON:0002038 | 71.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.31 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
7 targets.
| Target | Regulation |
|---|---|
| GPRASP3 | |
| ITGB1 | Unknown |
| KRAS | |
| MLH1 | |
| MOG | |
| SOCS1 | |
| SOS1 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2677.1 | HOXD1 | HOX |
JASPAR matrix evidence (PMIDs): PMID:33184220
Upstream regulators (CollecTRI, top): EZH2, RBPJ, THRA
miRNA regulators (miRDB)
77 targeting HOXD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
Literature-anchored findings (GeneRIF, showing 7)
- Single nucleotide polymorphism in HOXD1 is associated with ovarian cancer. (PMID:20852632)
- HOXD1 plays a significant role in endothelial cells functions by regulating the expression of ITGB1. (PMID:21501586)
- Data indicate that median methylation levels of BCAN, HOXD1, KCTD8, KLF11, NXPH1, POU4F1, SIM1, and TCF7L1 were >/=30% higher than in normal samples, representing potential biomarkers for tumor diagnosis. (PMID:22930747)
- HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma. (PMID:33559901)
- Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation. (PMID:37655555)
- A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma. (PMID:37827698)
- HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation. (PMID:39450540)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hoxd1 | ENSMUSG00000042448 |
| rattus_norvegicus | Hoxd1 | ENSRNOG00000001572 |
Paralogs (42): HOXA11 (ENSG00000005073), HOXC8 (ENSG00000037965), HOXA1 (ENSG00000105991), HOXA2 (ENSG00000105996), HOXA3 (ENSG00000105997), HOXA5 (ENSG00000106004), HOXA6 (ENSG00000106006), HOXA13 (ENSG00000106031), TLX1 (ENSG00000107807), HOXB6 (ENSG00000108511), TLX2 (ENSG00000115297), HOXB8 (ENSG00000120068), HOXB5 (ENSG00000120075), HOXB3 (ENSG00000120093), HOXB1 (ENSG00000120094), HOXA7 (ENSG00000122592), HOXC13 (ENSG00000123364), HOXC11 (ENSG00000123388), HOXC12 (ENSG00000123407), HOXD3 (ENSG00000128652), HOXD9 (ENSG00000128709), HOXD10 (ENSG00000128710), HOXD11 (ENSG00000128713), HOXD13 (ENSG00000128714), PDX1 (ENSG00000139515), HOXB13 (ENSG00000159184), TLX3 (ENSG00000164438), HOXD4 (ENSG00000170166), HOXD12 (ENSG00000170178), HOXB9 (ENSG00000170689), HOXC5 (ENSG00000172789), HOXB2 (ENSG00000173917), HOXD8 (ENSG00000175879), GSX2 (ENSG00000180613), HOXC9 (ENSG00000180806), HOXC10 (ENSG00000180818), HOXB4 (ENSG00000182742), HOXA4 (ENSG00000197576), HOXC6 (ENSG00000197757), HOXC4 (ENSG00000198353)
Protein
Protein identifiers
Homeobox protein Hox-D1 — Q9GZZ0 (reviewed: Q9GZZ0)
Alternative names: Homeobox protein Hox-GG
All UniProt accessions (1): Q9GZZ0
UniProt curated annotations — full annotation on UniProt →
Function. Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Acts on the anterior body structures.
Subcellular location. Nucleus.
Similarity. Belongs to the Antp homeobox family. Labial subfamily.
RefSeq proteins (1): NP_078777* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR020479 | HD_metazoa | Domain |
| IPR046327 | HXA1/B1/D1 | Family |
Pfam: PF00046
UniProt features (6 total): chain 1, DNA-binding region 1, region of interest 1, short sequence motif 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZZ0-F1 | 61.63 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis |
MSigDB gene sets: 110 (showing top):
GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, BENPORATH_ES_WITH_H3K27ME3, GOBP_SKELETAL_SYSTEM_DEVELOPMENT, GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT, GOBP_NEUROGENESIS, GOBP_SENSORY_PERCEPTION_OF_PAIN, SHIN_B_CELL_LYMPHOMA_CLUSTER_5, GATA1_04, GUO_HEX_TARGETS_UP, NKX25_01, RYTTCCTG_ETS2_B, GOBP_SENSORY_PERCEPTION, GOBP_EMBRYO_DEVELOPMENT, MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, GATA_Q6
GO Biological Process (5): regulation of transcription by RNA polymerase II (GO:0006357), sensory perception of pain (GO:0019233), neuron differentiation (GO:0030182), embryonic skeletal system development (GO:0048706), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Activation of HOX genes during differentiation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| sensory perception | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| skeletal system development | 1 |
| chordate embryonic development | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
Protein interactions and networks
STRING
842 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HOXD1 | LNPK | Q9C0E8 | 830 |
| HOXD1 | GTF3C3 | Q9Y5Q9 | 669 |
| HOXD1 | MTX2 | O75431 | 657 |
| HOXD1 | CHN1 | P15882 | 648 |
| HOXD1 | KCNH3 | Q9ULD8 | 607 |
| HOXD1 | CC2D1A | Q6P1N0 | 601 |
| HOXD1 | HOXD10 | P28358 | 575 |
| HOXD1 | HOXD11 | P31277 | 568 |
| HOXD1 | MDK | P21741 | 548 |
| HOXD1 | HOXD12 | P35452 | 520 |
| HOXD1 | SATB2 | Q9UPW6 | 450 |
| HOXD1 | TXNDC16 | Q9P2K2 | 437 |
| HOXD1 | HLA-DPB1 | P01916 | 429 |
| HOXD1 | COL5A2 | P05997 | 426 |
| HOXD1 | NIPAL2 | Q9H841 | 407 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HOXD1 | HOXB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HOXC9 | HOXD1 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (4): HOXD1 (Synthetic Lethality), HOXB1 (Affinity Capture-MS), HOXD1 (Affinity Capture-RNA), HOXD1 (Two-hybrid)
ESM2 similar proteins: A1YER7, A1YF08, A1YFD8, A1YFY3, A1YG85, A2D4P8, A2D4R4, A2D5I1, A2D649, A2T6H5, A2T6X6, A2T6Z0, A2T756, A2T7H5, A2T7J2, O35767, O43186, O88470, P06798, P09016, P10284, P10628, P17277, P17483, P18111, P23813, P31260, P31277, P31310, P42582, P43241, P43345, P47902, P52945, P52946, P52947, P52952, P57073, P58012, P70118
Diamond homologs: A1L2P5, A1YER7, A1YFD8, A1YFY3, A1YG01, A2D4P8, A2D4R4, A2D5I1, A2D5K9, A2D5Y4, A2D649, A2T6H5, A2T6X6, A2T6Z0, A2T7J2, A8DT10, A9L937, B0VXK3, O08656, O13074, O42365, O42366, O42367, O42368, O42370, O43364, O43365, O93353, P02831, P06798, P07548, P09016, P09017, P09021, P09022, P09027, P09070, P09638, P0C1T1, P10105
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| HOXD1 | “up-regulates quantity by expression” | ITGB1 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1695396 | Single allele | Pathogenic |
SpliceAI
157 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:176189449:GAAAG:G | donor_gain | 1.0000 |
| 2:176189450:AAAG:A | donor_gain | 1.0000 |
| 2:176189451:AAG:A | donor_gain | 1.0000 |
| 2:176189451:AAGG:A | donor_loss | 1.0000 |
| 2:176189452:AG:A | donor_gain | 1.0000 |
| 2:176189452:AGGT:A | donor_loss | 1.0000 |
| 2:176189453:GG:G | donor_gain | 1.0000 |
| 2:176189453:GGTA:G | donor_loss | 1.0000 |
| 2:176189454:G:GG | donor_gain | 1.0000 |
| 2:176189804:GCA:G | acceptor_loss | 1.0000 |
| 2:176189806:A:AG | acceptor_gain | 1.0000 |
| 2:176189806:AGGCA:A | acceptor_loss | 1.0000 |
| 2:176189807:G:GG | acceptor_gain | 1.0000 |
| 2:176189807:GGC:G | acceptor_gain | 0.9900 |
| 2:176189807:GGCA:G | acceptor_gain | 0.9900 |
| 2:176189807:GGCAA:G | acceptor_gain | 0.9900 |
| 2:176189654:G:GT | donor_gain | 0.9800 |
| 2:176189806:AG:A | acceptor_gain | 0.9800 |
| 2:176189807:GG:G | acceptor_gain | 0.9800 |
| 2:176189800:C:CA | acceptor_gain | 0.9700 |
| 2:176189454:G:T | donor_gain | 0.9600 |
| 2:176189655:A:T | donor_gain | 0.9600 |
| 2:176189799:AC:A | acceptor_gain | 0.9500 |
| 2:176189636:GCAT:G | donor_gain | 0.9400 |
| 2:176189803:T:TA | acceptor_gain | 0.9200 |
| 2:176189709:G:GT | donor_gain | 0.8900 |
| 2:176189800:C:G | acceptor_gain | 0.8500 |
| 2:176189677:TCCTG:T | donor_loss | 0.8200 |
| 2:176189678:CCTG:C | donor_loss | 0.8200 |
| 2:176189679:CTG:C | donor_loss | 0.8200 |
AlphaMissense
2098 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:176189861:T:C | F236L | 1.000 |
| 2:176189862:T:C | F236S | 1.000 |
| 2:176189862:T:G | F236C | 1.000 |
| 2:176189863:C:A | F236L | 1.000 |
| 2:176189863:C:G | F236L | 1.000 |
| 2:176189877:T:C | L241P | 1.000 |
| 2:176189886:T:C | L244P | 1.000 |
| 2:176189897:T:C | F248L | 1.000 |
| 2:176189898:T:C | F248S | 1.000 |
| 2:176189899:T:A | F248L | 1.000 |
| 2:176189899:T:G | F248L | 1.000 |
| 2:176189943:C:A | A263D | 1.000 |
| 2:176189981:T:A | W276R | 1.000 |
| 2:176189981:T:C | W276R | 1.000 |
| 2:176189983:G:C | W276C | 1.000 |
| 2:176189983:G:T | W276C | 1.000 |
| 2:176189984:T:A | F277I | 1.000 |
| 2:176189984:T:C | F277L | 1.000 |
| 2:176189984:T:G | F277V | 1.000 |
| 2:176189985:T:C | F277S | 1.000 |
| 2:176189985:T:G | F277C | 1.000 |
| 2:176189986:C:A | F277L | 1.000 |
| 2:176189986:C:G | F277L | 1.000 |
| 2:176189989:G:C | Q278H | 1.000 |
| 2:176189989:G:T | Q278H | 1.000 |
| 2:176189990:A:G | N279D | 1.000 |
| 2:176189993:C:A | R280S | 1.000 |
| 2:176189886:T:A | L244Q | 0.999 |
| 2:176189889:A:T | E245V | 0.999 |
| 2:176189890:A:C | E245D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000423196 (2:176191128 C>T), RS1001160152 (2:176189462 G>T), RS1002154023 (2:176189146 C>G,T), RS1003114523 (2:176187941 C>T), RS1003160256 (2:176188311 G>A,T), RS1003506594 (2:176188324 C>A,G,T), RS1003557592 (2:176188110 G>GA), RS1004884057 (2:176190227 G>A), RS1005238480 (2:176190605 T>C), RS1006462065 (2:176190328 A>C), RS1006512538 (2:176190701 G>A), RS1006689887 (2:176191168 G>A), RS1006958606 (2:176191356 G>A,T), RS1007782111 (2:176188428 A>G), RS1010473702 (2:176188516 G>A,C,T)
Disease associations
OMIM: gene MIM:142987 | disease phenotypes: MIM:606708
GenCC curated gene-disease
Mondo (1): split hand-foot malformation 5 (MONDO:0011709)
Orphanet (1): Isolated split hand-split foot malformation (Orphanet:2440)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000802_4 | Ovarian cancer | 5.000000e-14 |
| GCST002748_3 | Epithelial ovarian cancer | 9.000000e-14 |
| GCST003996_11 | Monobrow | 9.000000e-12 |
| GCST005166_2 | GIP levels in response to oral glucose tolerance test (120 minutes) | 2.000000e-08 |
| GCST006105_6 | Eye morphology | 9.000000e-07 |
| GCST006107_1 | Upper eyelid morphology | 2.000000e-07 |
| GCST006107_10 | Upper eyelid morphology | 4.000000e-06 |
| GCST006107_13 | Upper eyelid morphology | 1.000000e-07 |
| GCST006107_15 | Upper eyelid morphology | 4.000000e-09 |
| GCST006107_4 | Upper eyelid morphology | 9.000000e-08 |
| GCST006107_8 | Upper eyelid morphology | 7.000000e-09 |
| GCST006661_148 | Male-pattern baldness | 3.000000e-18 |
| GCST008747_175 | Estimated glomerular filtration rate | 3.000000e-13 |
| GCST008747_9 | Estimated glomerular filtration rate | 7.000000e-13 |
| GCST009391_579 | Metabolite levels | 7.000000e-07 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007906 | synophrys measurement |
| EFO:0004307 | glucose tolerance test |
| EFO:0008464 | glucose-dependent insulinotropic peptide measurement |
| EFO:0010501 | indole-3-propionate measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C564674 | Split-Hand-Foot Malformation 5 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
46 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases expression, increases methylation | 3 |
| Cyclosporine | decreases expression | 3 |
| Silicon Dioxide | increases expression, decreases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Tretinoin | increases expression | 2 |
| FR900359 | decreases phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | affects expression | 1 |
| titanium dioxide | decreases expression | 1 |
| trichostatin A | affects expression, decreases reaction | 1 |
| arsenite | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| tetrabromobisphenol A | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| resorcinol | increases expression | 1 |
| pentanal | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| entinostat | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Ethanol | decreases expression | 1 |
| Aldehydes | increases expression | 1 |
| Ampicillin | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Azathioprine | decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A3A5 | SEES3-1V human HOXD1, clone1 | Embryonic stem cell | Male |
| CVCL_A3A6 | SEES3-1V human HOXD1, clone2 | Embryonic stem cell | Male |
| CVCL_A3A7 | SEES3-1V human HOXD1, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): malignant epithelial tumor of ovary, split hand-foot malformation 5